Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126098231 | 12609823 | 1 | I | 20150731 | 20160801 | 20160801 | PER | US-DRREDDYS-USA/USA/15/0049813 | DR REDDYS | 48.00 | YR | F | Y | 0.00000 | 20160801 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126098231 | 12609823 | 1 | PS | OMEPRAZOLE MAGNESIUM DELAYED RELEASE OTC | OMEPRAZOLE MAGNESIUM | 1 | Oral | 79C408290 | 78878 | 20.6 | MG | CAPSULE | BID | ||||||
| 126098231 | 12609823 | 2 | C | morphine | MORPHINE | 1 | Unknown | 0 | |||||||||||
| 126098231 | 12609823 | 3 | C | hydrocodone | HYDROCODONE | 1 | Unknown | 0 | |||||||||||
| 126098231 | 12609823 | 4 | C | ALPRAZOLAM. | ALPRAZOLAM | 1 | Unknown | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126098231 | 12609823 | 1 | Gastrooesophageal reflux disease |
| 126098231 | 12609823 | 2 | Product used for unknown indication |
| 126098231 | 12609823 | 3 | Product used for unknown indication |
| 126098231 | 12609823 | 4 | Product used for unknown indication |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126098231 | 12609823 | Dysgeusia | |
| 126098231 | 12609823 | Extra dose administered |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |